查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012759

動物遺傳市場：依動物種類、技術、應用和最終用戶分類－2026-2032年全球市場預測

Animal Genetics Market by Animal Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，動物遺傳市場價值將達到 78.4 億美元，到 2026 年將成長到 85.8 億美元，到 2032 年將達到 158.8 億美元，複合年成長率為 10.59%。

主要市場統計數據
基準年 2025 78.4億美元
預計年份：2026年 85.8億美元
預測年份 2032 158.8億美元
複合年成長率 (%) 10.59%

本導言部分簡要概述了科學、商業、監管和倫理方面的變化，這些變化正在塑造現代動物遺傳學的創新和產業決策。

動物遺傳學領域如今在糧食安全、永續生產和轉化生物技術的交會點上發揮核心作用。分子工具和數據分析的科學進展正在加速遺傳變異的識別、檢驗和應用於育種計劃的速度。同時，私人企業和公共機構面臨錯綜複雜的倫理問題、不斷變化的法規以及相關人員期望，這些因素共同影響技術的應用路徑。

這種方法從結構上重建了動物遺傳學創新從實驗室環境發展到大規模部署的過程，整合了技術、監管和商業趨勢的整合。

動物遺傳學領域正經歷著一場變革性的轉變，這主要得益於精準生物學、計算分析技術的進步以及相關人員的正面影響。日益精密且應用廣泛的基因編輯工具使得以往僅停留在理論層面的標靶干預成為可能，而基因組選擇和高通量表現型分析則持續將大規模的資料集轉化為可操作的育種決策。這些技術進步與生殖技術和資料基礎設施的改進相輔相成，共同縮短了實用化時間，並降低了單位研發成本。

2025 年美國關稅調整如何加速供應鏈在地化和採購、夥伴關係以及國內能力建設的策略轉變。

貿易政策和關稅體系的變化將對供應鏈邏輯、採購決策以及跨境科研合作的經濟效益產生重大影響。 2025年，美國累積關稅調整不僅為國際基因投入品、定序設備和特殊試劑供應商帶來了新的考量，也為依賴進口基因材料和基因編輯平台的公司帶來了新的挑戰。這些政策措施凸顯了區域性供應鏈韌性的重要性，並促使相關人員重新評估籌資策略和夥伴關係的地域範圍。

一個策略性細分框架，將動物物種、底層技術、應用重點和最終用戶動機結合起來，以指導投資和開發決策。

精細的細分觀點闡明了生物學機會如何與商業性路徑和監管障礙相契合。就動物種類而言，研究和應用涵蓋水產養殖、牛、家禽和豬，其中牛又可進一步細分為牛和牛養殖，二者在育種目標、生產限制和價值促進因素方面均不相同。例如，高通量水產養殖計畫和多代牛養殖在生物學目標、育種週期和經濟獎勵方面存在顯著差異；因此，這些物種差異會影響技術優先排序和與最終用戶的互動。

區域分析揭示了美洲、歐洲、中東和非洲以及亞太地區在政策框架、能力水準和商業結構方面的差異如何影響技術的採用和推廣路徑。

區域趨勢對基因創新技術的監管、資金籌措和應用有顯著影響。在美洲，強勁的私營部門投資、一體化的價值鏈以及大規模的商業育種基礎設施，共同創造了一個有利環境，在明確的監管框架下，技術的實用化可以迅速擴展。北美和南美市場在消費者偏好和政策框架上的差異，影響技術採納的速度和方式，以及跨產業合作的性質。

深入了解企業策略、夥伴關係和能力整合，從而確定哪些組織能夠有效地將基因創新轉化為可擴展的商業解決方案。

動物遺傳學領域企業和機構的行動日益體現出科學專長與平台整合的整合。擁有強大知識產權組合、可擴展的實驗室工作流程和監管專業知識的技術供應商，能夠協助下游育種和商業化進程。許多機構正採取雙管齊下的策略：一方面自主開發核心平台功能，另一方面與商業育種者和研究機構合作，進行實地檢驗和產品推廣。

提出切實可行的建議，以協調技術優先順序、管治、供應鏈彈性和資料能力，從而加速負責任的部署和商業性成功。

產業領導者應採取組合式策略，兼顧短期營運收益和長期平台建設。優先發展諸如抗病性和飼料轉換率等高影響力應用項目，因為這些目標通常能即時降低生產風險和投入成本，從而為生產者帶來清晰可衡量的收益。此外，還應輔以對繁殖能力和產奶量提升等領域的選擇性投資，因為品種穩定性和長期遺傳資源管理能夠放大多個週期內的收益。

採用嚴謹的混合方法研究途徑，結合專家訪談、文獻整合、專利和政策審查以及情境分析，得出檢驗的產業見解。

本調查方法整合了定性和定量證據，旨在對動物遺傳學的現狀進行穩健且可重複的分析。初步調查包括對領域專家、育種者、監管專家和技術開發人員進行結構化訪談，以揭示公開文獻中未提及的實際情況、策略重點和挑戰。除了訪談外，還舉辦有針對性的研討會和專家小組會議，以檢驗新的假設並完善情境假設。

簡潔的結論平衡了動物遺傳學的科學潛力與有關監管、檢驗和相關人員接受度的實際考慮因素。

現代動物遺傳學生態系統蘊藏著巨大的機遇，但也受到複雜的監管、倫理和營運限制。基因編輯、基因組選擇和先進的生殖技術等技術手段為提高動物的抗病能力、飼料轉換率、繁殖力、生長速度和產奶量提供了精準的途徑。然而，大規模應用取決於科學檢驗、監管核准、供應鏈韌性和相關人員信心的協調一致。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：動物遺傳市場：依動物類型分類

  • 水產養殖
  • 牛
    • 牛
    • 牛
  • 家禽
  • 豬

第9章：動物遺傳市場：依技術分類

  • 複製技術
  • 基因編輯
    • CRISPR/Cas9
    • TALEN
    • ZFN
  • 基因組選擇
  • 標記輔助選擇

第10章：動物遺傳市場：依應用領域分類

  • 抗病性
  • 飼料效率
  • 生育力
  • 成長率
  • 產乳量

第11章：動物遺傳市場：依最終用戶分類

  • 學術機構
  • 商業育種者
  • 政府機構
  • 製藥公司
  • 研究機構

第12章：動物遺傳市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：動物遺傳市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 動物遺傳市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國動物遺傳市場

第16章：中國動物遺傳市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ABS Global Inc.
  • AgSource Genetics LLC
  • Alta Genetics Inc.
  • Animal Genetics Inc.
  • Aviagen Group Ltd.
  • Bovine Elite Inc.
  • CRV Holding BV
  • Envigo RMS LLC
  • Eurogene AI Services Ltd.
  • Genus plc
  • Groupe Grimaud SA
  • Hendrix Genetics BV
  • Neogen Corporation
  • Nugenomics Ltd.
  • PIC International Inc.
  • Select Sires Inc.
  • Semex Alliance
  • Sexing Technologies NV
  • STgenetics LLC
  • Swine Genetics International Inc.
  • Topigs Norsvin NV
  • Trans Ova Genetics LC
  • URUS Group LP
  • Zoetis Inc.
Product Code: MRR-4358BACA7E12

The Animal Genetics Market was valued at USD 7.84 billion in 2025 and is projected to grow to USD 8.58 billion in 2026, with a CAGR of 10.59%, reaching USD 15.88 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.84 billion
Estimated Year [2026] USD 8.58 billion
Forecast Year [2032] USD 15.88 billion
CAGR (%) 10.59%

A concise introduction outlining the evolving scientific, commercial, regulatory, and ethical landscape shaping modern animal genetics innovation and industry decision-making

The field of animal genetics now occupies a central role at the intersection of food security, sustainable production, and translational biotechnology. Scientific advances in molecular tools and data analytics have accelerated the pace at which genetic variation can be identified, validated, and applied to breeding programs. At the same time, commercial players and public institutions confront a complex web of ethical questions, evolving regulation, and shifting stakeholder expectations that shape deployment pathways.

This report synthesizes the contemporary drivers shaping animal genetics research and commercialization, emphasizing the practical implications for researchers, breeders, policy makers, and investors. It frames the sector in terms of technological capability, application-driven value, and institutional adoption patterns. By integrating evidence from laboratory innovations, product development pipelines, and regulatory signals, the introduction grounds readers in the landscape's critical tensions and opportunities.

Readers should expect a balanced perspective that pairs technical clarity with strategic insight. The goal is to equip decision-makers with a framework that clarifies where scientific promise aligns with feasible implementation, where barriers remain most material, and where near-term actions can create durable advantage across diverse organizational objectives.

An integrated view of converging technological, regulatory, and commercial trends that are structurally reshaping how animal genetics innovations progress from lab to large-scale deployment

The animal genetics landscape is in the midst of transformative shifts driven by converging advances in precision biology, computational analytics, and stakeholder influence. Gene editing tools, increasingly refined and democratized, are enabling targeted interventions that were previously theoretical, while genomic selection and high-throughput phenotyping are turning large datasets into consistently actionable breeding decisions. These technological shifts are complemented by improvements in reproductive technologies and data infrastructure that together compress translational timelines and lower per-unit development costs.

Concurrently, societal and regulatory vectors are reshaping deployment strategies. Public scrutiny of genetic interventions, elevated attention to animal welfare, and heightened expectations for transparency are prompting companies and institutions to design pathways that prioritize traceability, rigorous safety assessment, and meaningful stakeholder engagement. Policy environments are also evolving; some jurisdictions pursue enabling frameworks for responsibly managed gene editing, while others emphasize precaution. This regulatory heterogeneity is catalyzing strategic segmentation across markets, with agile organizations investing in modular development plans that can be adapted to divergent approval pathways.

Commercially, partnerships between technology originators, commercial breeders, and product integrators are becoming the predominant model for scaling. Vertical integration and consortium-style collaborations are emerging as pragmatic ways to share development risk, consolidate expertise, and accelerate access to end users. Taken together, these trends are not merely incremental; they represent a structural reconfiguration of how genetic science moves from laboratory proofs to operational use in animal populations.

How recent United States tariff adjustments in 2025 accelerated supply-chain regionalization and strategic shifts across procurement, partnerships, and domestic capacity building

Changes in trade policy and tariff regimes can produce material shifts in supply chain logic, sourcing decisions, and the economics of cross-border research collaborations. In 2025, cumulative tariff adjustments in the United States introduced new considerations for international suppliers of genetic inputs, sequencing equipment, and specialized reagents, as well as for firms that rely on imported genetic materials or gene-editing platforms. These policy moves have amplified the importance of localized supply resilience and have prompted stakeholders to re-evaluate procurement strategies and partnership geographies.

As a result, many firms responded by diversifying supplier networks, expanding regional manufacturing capacity, and accelerating qualification of alternative vendors to reduce single-source dependencies. Research collaborations and trial pipelines adjusted timelines to account for possible customs delays and increased documentation requirements. For breeding programs that import genetic material or rely on cross-border exchange of germplasm, the tariff environment created additional administrative complexity and incremental cost pressure that affected operational prioritization.

Importantly, these policy shifts also reanimated discussions about domestic capability building. Public and private actors moved to support local infrastructure investments, from cryopreservation facilities to sequencing and bioinformatics platforms, in order to preserve strategic autonomy and protect breeding timelines. While tariffs did not change the underlying scientific potential, they acted as an accelerant for regionalization and supply-chain modernization strategies which will continue to influence project design and partnership choices going forward.

A strategic segmentation framework that aligns animal types, enabling technologies, application priorities, and end-user motivations to guide investment and development decisions

A nuanced segmentation view clarifies where biological opportunity aligns with commercial pathways and regulatory friction. When considering animal type, research and applications span aquaculture, cattle, poultry, and swine, with cattle further differentiated into beef and dairy enterprises that have distinct breeding objectives, production constraints, and value drivers. These animal-type distinctions influence prioritization of technologies and end-user engagement because the biological targets, breeding cycles, and economic incentives differ markedly between, for example, a high-throughput aquaculture program and a multi-generational beef cattle herd.

From a technology standpoint, the sector now deploys cloning, gene editing, genomic selection, and marker assisted selection in complementary ways. Within gene editing, techniques such as CRISPR/Cas9, TALEN, and ZFN present different trade-offs of precision, ease of adoption, and regulatory recognition, and these technical attributes inform which tools are suitable for pathway-specific goals. Aligning technology choice with application needs is crucial because the same genomic tool can be optimized for disease resistance, feed efficiency, fertility, growth rate, or milk production depending on experimental design and validation strategy.

Application-driven segmentation reveals that objectives like disease resistance and feed efficiency often deliver cross-sector value by reducing production risk and input costs, while fertility, growth rate, and milk production are tightly linked to breed-specific commercial objectives. End users encompass academic institutes, commercial breeders, government agencies, pharmaceutical companies, and research institutes, and each group brings different incentives, operational tempos, and risk tolerances to development programs. Taken together, this segmentation framework provides a practical lens to prioritize investments, design validation pathways, and map the stakeholders that must be engaged to move innovations into routine practice.

A regional analysis revealing how divergent policy regimes, capacity levels, and commercial structures across the Americas, Europe Middle East & Africa, and Asia-Pacific shape adoption and scale-up pathways

Regional dynamics materially influence how genetic innovations are regulated, funded, and adopted. In the Americas, strong private-sector investment, integrated value chains, and a large commercial breeding infrastructure create an environment where translational work can scale quickly once regulatory clarity is achieved. North and South American markets present differentiated consumer preferences and policy frameworks, which in turn shape the pace and modalities of technology deployment and industry collaboration.

Europe, the Middle East, and Africa present a mosaic of regulatory philosophies and capacity levels. The European sphere often emphasizes precaution, traceability, and extensive stakeholder consultation, which influences product design and communications strategy. By contrast, parts of the Middle East and Africa are prioritizing rapid productivity gains through targeted breeding initiatives, often supported by public investment and international partnerships. These regional differences necessitate adaptive regulatory strategies and locally relevant demonstration projects to build credibility and operational buy-in.

Asia-Pacific reflects high heterogeneity but shares common features of strong government-led R&D priorities, rapid adoption of digital agricultural tools, and concentrated pockets of industrial-scale aquaculture and livestock production. Countries in this region are investing in genomic infrastructure and public-private collaborations to address food security and export competitiveness. Collectively, regional variation underscores the importance of tailoring development pipelines, regulatory engagement, and stakeholder outreach to the specific socio-political and economic realities of each geographic context.

Insight into corporate strategies, partnerships, and capability consolidation that determine which organizations effectively translate genetics innovations into scalable commercial solutions

Corporate and institutional behavior in animal genetics increasingly reflects a blend of scientific specialization and platform consolidation. Technology providers that combine robust intellectual property portfolios with scalable laboratory workflows and regulatory expertise are positioned to act as enablers for downstream breeding and productization. Many organizations pursue a dual strategy of in-house development for core platform capabilities while partnering with commercial breeders and research institutes for field validation and distribution.

Strategic alliances are a common pattern: technology originators collaborate with breeding companies to integrate genomic solutions into existing pipelines, while contract research organizations and service laboratories offer assay standardization and regulatory dossier support. Investment in proprietary data assets and phenotype-linked genomic databases has emerged as a competitive differentiator because it underpins model accuracy and product predictability. At the same time, companies that prioritize transparent validation, third-party replication, and engagement with regulatory authorities reduce time-to-market risk and enhance stakeholder trust.

Mergers and acquisitions remain an important avenue for capability acquisition, particularly where firms seek to combine molecular toolkits with animal breeding expertise or to secure access to regionally important germplasm and distribution channels. Across the ecosystem, successful companies balance scientific excellence with pragmatic commercialization pathways, invest in regulatory and ethical governance, and maintain flexible partnership models that permit rapid scaling when technical and market signals align.

Actionable and practical recommendations that align technology prioritization, governance, supply resilience, and data capabilities to accelerate responsible deployment and commercial success

Industry leaders should pursue a portfolio approach that balances near-term operational gains with longer-term platform creation. Prioritize projects that address high-impact applications such as disease resistance and feed efficiency because these objectives often yield immediate reductions in production risk and input costs while providing clear, measurable benefits to producers. Complement these efforts with selective investments in fertility and milk production improvements where breed stability and long-term genetic stewardship can amplify returns over multiple cycles.

Governance and stakeholder engagement are equally important. Establish transparent validation pipelines, publish replication studies where feasible, and engage with regulators early to align on acceptable evidence thresholds. Proactively design animal welfare assessments and public communication strategies to build social license. From an operational perspective, diversify supplier relationships, qualify regional manufacturing and sequencing capacity, and embed scenario planning to absorb policy or trade disruptions. Leverage partnerships with academic institutes and research organizations to access specialized expertise and to share validation burden.

Finally, invest in data infrastructure and human capital. High-quality phenotype-linked genomic databases, interoperable analytics platforms, and skilled multidisciplinary teams are essential to convert laboratory innovations into reproducible field outcomes. By integrating scientific rigor with adaptive commercialization plans and robust stakeholder engagement, industry leaders can accelerate responsible deployment while managing risk and enhancing long-term value creation.

A rigorous mixed-methods research approach combining expert interviews, literature synthesis, patent and policy review, and scenario analysis to produce validated industry insights

The research methodology combines qualitative and quantitative evidence streams to produce a robust, reproducible analysis of the animal genetics landscape. Primary research included structured interviews with domain experts, breeders, regulatory specialists, and technology developers to capture operational realities, strategic priorities, and pain points that are not visible in published literature. These interviews were complemented by targeted workshops and expert panels that validated emerging hypotheses and refined scenario assumptions.

Secondary research incorporated a systematic review of peer-reviewed literature, patent filings, regulatory guidance documents, and technical whitepapers to map technological trajectories and identify validated use cases. In addition, comparative policy analysis examined jurisdictional approaches to gene editing, traceability, and animal welfare to inform region-specific recommendations. Data synthesis leveraged cross-validation between primary insights and documented evidence, and findings were stress-tested through scenario analysis to explore plausible policy and market evolutions.

Finally, methodological rigor was maintained through iterative validation steps and transparent documentation of data sources and analytical assumptions. Where uncertainty remained, conservative inference principles were applied and alternative interpretations were described to ensure readers can assess risk and applicability to their own decision contexts.

A concise concluding synthesis that balances the scientific promise of animal genetics with pragmatic considerations for regulation, validation, and stakeholder acceptance

The contemporary animal genetics ecosystem presents significant opportunities tempered by complex regulatory, ethical, and operational constraints. Technological tools such as gene editing, genomic selection, and advanced reproductive methods provide precise levers to improve disease resistance, feed efficiency, fertility, growth rate, and milk production. However, adoption at scale depends on alignment between scientific validation, regulatory acceptance, supply-chain resilience, and stakeholder trust.

Strategic differentiation will come from organizations that integrate scientific excellence with adaptive commercialization strategies: those that invest in high-quality phenotype-linked data, design rigorous and transparent validation programs, and cultivate partnerships that bridge laboratory innovation with field implementation. Regional policy diversity and evolving trade environments demand flexible plans that can be localized while preserving global interoperability. By prioritizing applications that reduce production risk and by building governance practices that anticipate societal concerns, stakeholders can responsibly accelerate translational progress.

In sum, the sector is moving from exploratory research toward practical, deployable interventions. The path forward emphasizes pragmatic science, robust validation, and proactive engagement with regulators and the public to ensure genetic innovations deliver durable benefits across production, health, and sustainability objectives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Genetics Market, by Animal Type

  • 8.1. Aquaculture
  • 8.2. Cattle
    • 8.2.1. Beef Cattle
    • 8.2.2. Dairy Cattle
  • 8.3. Poultry
  • 8.4. Swine

9. Animal Genetics Market, by Technology

  • 9.1. Cloning
  • 9.2. Gene Editing
    • 9.2.1. CRISPR/Cas9
    • 9.2.2. TALEN
    • 9.2.3. ZFN
  • 9.3. Genomic Selection
  • 9.4. Marker Assisted Selection

10. Animal Genetics Market, by Application

  • 10.1. Disease Resistance
  • 10.2. Feed Efficiency
  • 10.3. Fertility
  • 10.4. Growth Rate
  • 10.5. Milk Production

11. Animal Genetics Market, by End User

  • 11.1. Academic Institutes
  • 11.2. Commercial Breeders
  • 11.3. Government Agencies
  • 11.4. Pharmaceutical Companies
  • 11.5. Research Institutes

12. Animal Genetics Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Animal Genetics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Animal Genetics Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Animal Genetics Market

16. China Animal Genetics Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. ABS Global Inc.
  • 17.6. AgSource Genetics LLC
  • 17.7. Alta Genetics Inc.
  • 17.8. Animal Genetics Inc.
  • 17.9. Aviagen Group Ltd.
  • 17.10. Bovine Elite Inc.
  • 17.11. CRV Holding B.V.
  • 17.12. Envigo RMS LLC
  • 17.13. Eurogene AI Services Ltd.
  • 17.14. Genus plc
  • 17.15. Groupe Grimaud S.A.
  • 17.16. Hendrix Genetics BV
  • 17.17. Neogen Corporation
  • 17.18. Nugenomics Ltd.
  • 17.19. PIC International Inc.
  • 17.20. Select Sires Inc.
  • 17.21. Semex Alliance
  • 17.22. Sexing Technologies N.V.
  • 17.23. STgenetics LLC
  • 17.24. Swine Genetics International Inc.
  • 17.25. Topigs Norsvin N.V.
  • 17.26. Trans Ova Genetics LC
  • 17.27. URUS Group LP
  • 17.28. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL GENETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL GENETICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANIMAL GENETICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANIMAL GENETICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL GENETICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ANIMAL GENETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ANIMAL GENETICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL GENETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANIMAL GENETICS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL GENETICS MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL GENETICS MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL GENETICS MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL GENETICS MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL GENETICS MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL GENETICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL GENETICS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL GENETICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL GENETICS MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL GENETICS MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL GENETICS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CLONING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CLONING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CLONING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CRISPR/CAS9, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CRISPR/CAS9, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TALEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TALEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TALEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ZFN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ZFN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ZFN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENOMIC SELECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENOMIC SELECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENOMIC SELECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MARKER ASSISTED SELECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MARKER ASSISTED SELECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MARKER ASSISTED SELECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DISEASE RESISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DISEASE RESISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FEED EFFICIENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FEED EFFICIENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FEED EFFICIENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FERTILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FERTILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FERTILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROWTH RATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROWTH RATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROWTH RATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MILK PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MILK PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MILK PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COMMERCIAL BREEDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COMMERCIAL BREEDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COMMERCIAL BREEDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GOVERNMENT AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GOVERNMENT AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL GENETICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL GENETICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL GENETICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL GENETICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL GENETICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL GENETICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL GENETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS ANIMAL GENETICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. GCC ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. GCC ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. GCC ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 147. GCC ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. GCC ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. G7 ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. G7 ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 168. G7 ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. G7 ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. NATO ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. NATO ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 173. NATO ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. NATO ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 175. NATO ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. NATO ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ANIMAL GENETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA ANIMAL GENETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)